how to wean off retatrutide in adults with obesity over 104 weeks in the highest dose group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 Switching from tirzepatide to retatrutide:

Data contained demographics, comorbidity, pre-operative blood tests and length of stay (LOS) after surgery, defined as an overnight stay

Bawa T, Dhingra V, Malhotra N, Wasir JS, Mithal A

"Body composition outcomes in obesity pharmacotherapy: clinical significance and measurement challenges." Reviews in Endocrine and Metabolic Disorders

Personalization is key

Serum ALC was negatively correlated with LDL-C in hypercholesterolemic individuals Metabolomic qualitative and quantitative assessments of the patients plasma and clinical characteristics revealed that plasma ALC was significantly downregulated

The data on cardiovascular protection, bone density, and cognitive health is beyond compelling, especially when started in perimenopause or close to menopause